B. BRAUN SE
Company Snapshot
Company Overview
B. Braun SE, founded in 1839 in Germany, is a global provider of healthcare products and services. The company develops a broad portfolio of medical solutions, including products for intensive care units, anesthesia and emergency care, extracorporeal blood treatment, cardiology, surgical core procedures, nutritional therapy, etc.
The company operates through four divisions: B. Braun Hospital Care, B. Braun Aesculap, B. Braun Outpatient Market, and B. Braun Avitum. B. Braun Aesculap focuses on therapeutic areas, including abdominal surgery, cardiothoracic surgery, interventional vascular therapy, neurosurgery orthopedic surgery, spine surgery, and sterile goods management. It offers surgical and interventional products under this segment.
B. Braun has over 64,000 employees across over 300 subsidiaries in 64 countries. Its portfolio includes 5,000 healthcare products.
Financial Highlights (FY 2023)
This information is available for BCC Research members only.
B. BRAUN SE In News
Applications/End User Industries
- Extracorporeal Blood Purification Therapies
- Acute Blood Purification
- Acute Therapies
- Apheresis Treatment
- Implantology
- Sutures
- Infection Prevention and Control (IPC)
- Infusion Therapy
- Fluid and Electrolyte Therapy
- Vascular Intervention Therapy and Diagnostics
- Coronary Angioplasty
- Neurosurgery
- Gravitational Valves
- Aneurysm Treatment
- Nutrition Therapy
- Oncology
- Chemotherapy
- Ostomy
- Anesthesia
- Spine Surgery
